Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.11.18 (
MAP
)
7,412
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rats received once daily injections of methamphetamine (
MAP
; 4 mg/kg/day) intraperitoneally, at most 100 times. Enhanced ambulatory activity by
MAP
reduced during the long-term administration of
MAP
. The mean rating score of
MAP
-induced abnormal behavior, including locomotion, stereotyped behavior, motor inhibition and the response to acoustic stimulation, increased until 56th injection of
MAP
. But after that, the score tended to decrease mainly because the injected
MAP
failed to keep the movement of rats reduced under acoustic stimulation. Neither the time course of these rating score nor the decrease in [3H] spiperone binding sites, examined after the injection of
MAP
100 times, seemed to develop along with the repeated
MAP
administration. Thus, the changes in both behavior and [3H] spiperone binding sites produced by repeated
MAP
would not necessarily indicate the symptoms of
MAP
-
induced psychosis
in man, because the susceptibility to psychosis in man increases along with the time of
MAP
injection. It is presumed that the animal model of psychosis produced by administration of
MAP
is important not as a model of psychotic symptoms, but as a model of increased susceptibility to psychosis induced by
MAP
.
...
PMID:[Chronological change in abnormal behavior produced by long-term methamphetamine administration in the rat]. 407 36
It has been suggested that individual genetic factors are involved in susceptibility to drug dependence and the manifestation of drug-
induced psychosis
. The aim of this study was to examine the relation between methamphetamine abusers/psychosis and the type 1 sigma receptor gene polymorphisms. Subjects comprised 143
MAP
abusers and 181 healthy controls. Two polymorphisms in the type 1 sigma receptor gene, GC-241-240TT and A61C (Gln2Pro), were examined in the present study. No significant differences were observed in either polymorphism between healthy controls and
MAP
abusers/psychosis. In the subgroup analyses, the rate of CC genotype of A61C tended to be higher in
MAP
patients who had experienced spontaneous relapse without
MAP
use than in those who had not (P = .06, OR = 3.02 95%CI = 0.92-9.92). However, the level of this significant trend did not remain after the Bonferroni's multiple correction. This study suggests that type 1 sigma receptor gene is unlikely to play a major role in substance abuse liability and/or the development of
MAP
psychosis.
...
PMID:No association found between the type 1 sigma receptor gene polymorphisms and methamphetamine abuse in the Japanese population: a collaborative study by the Japanese Genetics Initiative for Drug Abuse. 1554 96
The goal of this study was to extend our previous research that reported a significant association between Attention Deficit Hyperactivity Disorder (ADHD)-relevant childhood behaviors and the frequency of methamphetamine (MA)-induced psychotic symptoms in an expanded sample. 190 participants who met DSM-IV criteria for MA dependence were administered the Methamphetamine Experience Questionnaire that assessed MA-
induced psychosis
. Data related to MA exposure, comorbid drug use, education, familial psychiatric history and assessments of ADHD-relevant childhood behaviors as measured by the Wender Utah Rating Scale (WURS) were collected. Although WURS scores did not differ between 145 MAP+ and 45
MAP
- subjects, MAP+ subjects with higher WURS scores were significantly more likely to report more frequent psychosis. Although mean daily MA dosage did not differ between the MAP+ and
MAP
- subjects, MAP+ subjects who consumed larger doses of MA were significantly more likely to experience frequent psychosis. These data suggest that ADHD-relevant childhood behaviors may interact with MA exposure to reflect a neurobiological vulnerability related to the emergence of frequent MA-induced psychotic symptoms. These results may elucidate factors that contribute to the psychiatric sequelae of MA abuse.
...
PMID:Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure. 2389 55